The shifting UK scene surrounding psychedelics is increasingly nuanced, demanding careful assessment. While therapeutic investigation into compounds like psilocybin and copyright continues to advance, and patient access via private clinics is increasing, the legal framework remains ambiguous. This presents a challenging situation for both indivi⦠Read More